Average weight loss ranges from 9.2-12.4 kg (20-27 pounds) over 68 weeks, with most patients seeing noticeable results by 12 weeks
We also offer Medfertil which improves sperm motility, DNA integrity, and sperm count
While we encourage adaptability, consulting with your healthcare provider before altering your tirzepatide regimen is crucial
Fasting While on Tirzepatide: Safety Considerations Intermittent fasting (IF) during tirzepatide therapy is possible for many patients but requires attention to hydration, electrolyte balance, and nutrient timing
The subjects were randomly assigned to receive subcutaneous semaglutide at doses of 0.5 mg or comparator medications (placebo, sitagliptin, exenatide extended-release, or insulin glargine)
According to the FDA prescribing information, gastrointestinal adverse reactions are very common, with nausea (24-37%), diarrhea (18-26%), vomiting (8-25%), and constipation (16-24%) occurring frequently across clinical trials